Beijing Lianxin Pharmaceutical
founded 1999 by the Institute of Materia Medica of the Chinese Academy of Medical Sciences alongside Shandong Hongjitang Pharmaceutical Group, Shanghai Yaocai and China TCM Co.;…
- Country
- China
State Class-1 new-drug status, National S&T Progress Award
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsreachnmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic musk & aromas | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.